ENDPOINTS

FDA loosens safety requirements for CAR-Ts in move to boost access

The FDA is eliminating a safety monitoring program for all CAR-T therapies, saying the cell therapies can be used safely and effectively without it. The agency said Thursday it determined the ...

Jun 27, 2025 - 18:12
 0
FDA loosens safety requirements for CAR-Ts in move to boost access
The FDA is eliminating a safety monitoring program for all CAR-T therapies, saying the cell therapies can be used safely and effectively without it. The agency said Thursday it determined the ...
Read More

Tags:

Previous Article

Rice rebels: Research reveals grain's brewing benefits

Next Article

Mathematicians create a tetrahedron that always lands on the same side

Related Posts

Roche’s 96-week data for multiple sclerosis drug; ZymeWorks claims $20M milestone

Roche’s 96-week data for multiple sclerosis drug; ZymeW...

May 30, 2025  0

Rebooting dead human brains, biotech seeks to reinvent drug testing work

Rebooting dead human brains, biotech seeks to reinvent ...

Jun 10, 2025  0

HHS issues guidance for third round of drug price negotiations

HHS issues guidance for third round of drug price negot...

May 13, 2025  0